Over the course of the 1980s, companies attempted to develop new organ
isational strategies to balance competition with collaboration. Althou
gh a variety of theoretical frameworks acknowledged this development t
here have been very few empirical studies in which the nature and exte
nt of this collaborative integration and the implications for industri
es in the 1990s have been examined. In this paper, the Canadian pharma
ceutical industry is used as the empirical context for an examination
of collaboration. The author focuses on the relationship between small
and large firms, biotechnology-based companies, and university resear
ch and argues that these collaborative linkages need to be more firmly
developed in our theoretical discussions if we are to make sense of t
he corporate world in the 1990s.